Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 4.208 |
|
|||||
| News | - |
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Sunshine Biopharma Inc | SBFMW | NASDAQ | Equity Warrant |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,0025 | -5,00% | 0,0475 | 20:14:51 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,069 | 0,0475 | 0,069 | 0,05 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen |
|---|---|---|---|---|
| 27 | 4.208 | 0,0665545 | 280 | - |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 19:51:14 | 100 | 0,0475 | USD |
Finanzwerte SBFMW
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 100,87k | - | - | - | -0,02 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Sunshine Biopharma
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 08.6.2026 | 22:05 | Edgar (US Regulatory) | Form DEF 14C - Other definitive information statements |
| 29.5.2026 | 22:06 | Edgar (US Regulatory) | Form PRE 14C - Other preliminary information statements |
| 29.5.2026 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22.5.2026 | 22:10 | Edgar (US Regulatory) | Form SCHEDULE 13G - Statement of Beneficial Ownership by.. |
| 19.5.2026 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 19.5.2026 | 17:03 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 13.5.2026 | 22:18 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 12.5.2026 | 22:16 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 09.4.2026 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 03.4.2026 | 17:58 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 09.3.2026 | 21:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 02.3.2026 | 22:05 | Edgar (US Regulatory) | Form DEF 14C - Other definitive information statements |
Forum Sunshine Biopharma
Keine Diskussionen Gefunden.Neuen Thread Erstellen
SBFMW Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
NASDAQ:SBFMW -
What is the current Sunshine Biopharma Inc share price?
The current share price of Sunshine Biopharma Inc is US$ 0,0475
What is the 1 year trading range for Sunshine Biopharma Inc share price?
Sunshine Biopharma Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year
